CCWM
PGEN icon

Cassaday & Co Wealth Management’s Precigen PGEN Stock Holding History

Cassaday & Co Wealth Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,000
Closed -$38K – 260
2022
Q4 		$38K Buy
+25,000
New +$43K ﹤0.01% 253

Other funds holding PGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cassaday & Co Wealth Management's PGEN Position: Q1 2023 in Review

Cassaday & Co Wealth Management sold out of Precigen (PGEN) in Q1 2023, closing a stake of 25,000 shares — an estimated $38K sold.

Cassaday & Co Wealth Management first reported a position in PGEN in Q4 2022 and held it in 1 quarter. The position peaked at $38K in Q4 2022. 157 funds tracked by Wall St. Rank hold PGEN as of Q1 2023.

  • Cassaday & Co Wealth Management reported no remaining Precigen position as of Q1 2023 after selling out during the quarter.
  • Cassaday & Co Wealth Management sold 25,000 Precigen shares in Q1 2023, an estimated $38K.
  • Cassaday & Co Wealth Management first reported a position in Precigen in Q4 2022 and held it in 1 quarter.
  • Cassaday & Co Wealth Management's Precigen position peaked at $38K in Q4 2022.
  • 157 funds tracked by Wall St. Rank held Precigen as of Q1 2023.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2023, filed 3 May 2023.